Efficient and selective kidney targeting by chemically modified carbohydrate conjugates
Authors:
Open Access
- 12 November 2024
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 32 (12) , 4383-4400
Abstract
No abstract availableKeywords
Funding Information
- University of Connecticut
This publication has 56 references indexed in Scilit:
- RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challengesAdvanced Drug Delivery Reviews, 2023
- Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of HepatocytesAdvanced Healthcare Materials, 2023
- Modified chitosan for effective renal delivery of siRNA to treat acute kidney injuryBiomaterials, 2022
- Antisense technology: A reviewJournal of Biological Chemistry, 2021
- The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticlesBioengineering & Translational Medicine, 2020
- Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl- polyethylenimine -containing nanoplexesInternational Journal of Pharmaceutics, 2017
- Nanotechnology for delivery of peptide nucleic acids (PNAs)Journal of Controlled Release, 2016
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotidesAdvanced Drug Delivery Reviews, 2015
- Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells☆Advanced Drug Delivery Reviews, 2010
- Models of chronic kidney diseaseDrug Discovery Today: Disease Models, 2010